149 related articles for article (PubMed ID: 32034698)
21. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.
Burton JP; Wescombe PA; Macklaim JM; Chai MH; Macdonald K; Hale JD; Tagg J; Reid G; Gloor GB; Cadieux PA
PLoS One; 2013; 8(6):e65991. PubMed ID: 23785463
[TBL] [Abstract][Full Text] [Related]
22. Effect of Probiotic Lactobacillus salivarius on Peri-Implantitis Pathogenic Bacteria: An In Vitro Study.
Mulla M; Hegde S; Koshy A; Mulla M
Cureus; 2021 Dec; 13(12):e20808. PubMed ID: 35111477
[TBL] [Abstract][Full Text] [Related]
23. Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens.
Chen YT; Hsieh PS; Ho HH; Hsieh SH; Kuo YW; Yang SF; Lin CW
Lett Appl Microbiol; 2020 Apr; 70(4):310-317. PubMed ID: 31955445
[TBL] [Abstract][Full Text] [Related]
24. Heat-killed Lactobacillus reuteri and cell-free culture supernatant have similar effects to viable probiotics during interaction with Porphyromonas gingivalis.
Geraldo BMC; Batalha MN; Milhan NVM; Rossoni RD; Scorzoni L; Anbinder AL
J Periodontal Res; 2020 Apr; 55(2):215-220. PubMed ID: 31691977
[TBL] [Abstract][Full Text] [Related]
25. Antagonistic trait of Lactobacillus reuteri S5 against Salmonella enteritidis and assessment of its potential probiotic characteristics.
Shi S; Qi Z; Sheng T; Tu J; Shao Y; Qi K
Microb Pathog; 2019 Dec; 137():103773. PubMed ID: 31604155
[TBL] [Abstract][Full Text] [Related]
26. Lactobacillus salivarius NK02: a Potent Probiotic for Clinical Application in Mouthwash.
Sajedinejad N; Paknejad M; Houshmand B; Sharafi H; Jelodar R; Shahbani Zahiri H; Noghabi KA
Probiotics Antimicrob Proteins; 2018 Sep; 10(3):485-495. PubMed ID: 28631250
[TBL] [Abstract][Full Text] [Related]
27. In Vitro Selection of
Zanetta P; Squarzanti DF; di Coste A; Rolla R; Valletti PA; Garzaro M; Dell'Era V; Amoruso A; Pane M; Azzimonti B
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555802
[TBL] [Abstract][Full Text] [Related]
28. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study.
Teughels W; Durukan A; Ozcelik O; Pauwels M; Quirynen M; Haytac MC
J Clin Periodontol; 2013 Nov; 40(11):1025-35. PubMed ID: 24164569
[TBL] [Abstract][Full Text] [Related]
29.
Hsieh PS; Ho HH; Hsieh SH; Kuo YW; Tseng HY; Kao HF; Wang JY
BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32332068
[TBL] [Abstract][Full Text] [Related]
30. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial.
Burton JP; Drummond BK; Chilcott CN; Tagg JR; Thomson WM; Hale JDF; Wescombe PA
J Med Microbiol; 2013 Jun; 62(Pt 6):875-884. PubMed ID: 23449874
[TBL] [Abstract][Full Text] [Related]
31. Does Streptococcus Salivarius Strain M18 Assumption Make Black Stains Disappear in Children?
Bardellini E; Amadori F; Gobbi E; Ferri A; Conti G; Majorana A
Oral Health Prev Dent; 2020 Apr; 18():161-164. PubMed ID: 32099975
[TBL] [Abstract][Full Text] [Related]
32. Safety assessment of
Hale JDF; Jain R; Wescombe PA; Burton JP; Simon RR; Tagg JR
Benef Microbes; 2022 Feb; 13(1):47-60. PubMed ID: 35098909
[TBL] [Abstract][Full Text] [Related]
33. Lactobacillus reuteri ATCC 55730 and L22 display probiotic potential in vitro and protect against Salmonella-induced pullorum disease in a chick model of infection.
Zhang D; Li R; Li J
Res Vet Sci; 2012 Aug; 93(1):366-73. PubMed ID: 21764090
[TBL] [Abstract][Full Text] [Related]
34. Antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines.
Ang LY; Too HK; Tan EL; Chow TK; Shek LP; Tham EH; Alonso S
Virol J; 2016 Jun; 13():111. PubMed ID: 27341804
[TBL] [Abstract][Full Text] [Related]
35. Investigation of probiotic bacteria as dental caries and periodontal disease biotherapeutics.
Saha S; Tomaro-Duchesneau C; Rodes L; Malhotra M; Tabrizian M; Prakash S
Benef Microbes; 2014 Dec; 5(4):447-60. PubMed ID: 25006013
[TBL] [Abstract][Full Text] [Related]
36. In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications.
Gangaiah D; Mane SP; Tawari NR; Lakshmanan N; Ryan V; Volland A; Susanti D; Patel M; Abouzeid A; Helmes EB; Kumar A
PLoS One; 2022; 17(1):e0262663. PubMed ID: 35081129
[TBL] [Abstract][Full Text] [Related]
37. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial.
Iniesta M; Herrera D; Montero E; Zurbriggen M; Matos AR; Marín MJ; Sánchez-Beltrán MC; Llama-Palacio A; Sanz M
J Clin Periodontol; 2012 Aug; 39(8):736-44. PubMed ID: 22694350
[TBL] [Abstract][Full Text] [Related]
38. Coaggregation between probiotic bacteria and caries-associated strains: an in vitro study.
Twetman L; Larsen U; Fiehn NE; Stecksén-Blicks C; Twetman S
Acta Odontol Scand; 2009; 67(5):284-8. PubMed ID: 19479452
[TBL] [Abstract][Full Text] [Related]
39. Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis.
Piccioni A; Franza L; Vaccaro V; Saviano A; Zanza C; Candelli M; Covino M; Franceschi F; Ojetti V
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441008
[TBL] [Abstract][Full Text] [Related]
40. Lactobacillus reuteri DSM 17938-A comparative study on the effect of probiotics and lysates on human skin.
Khmaladze I; Butler É; Fabre S; Gillbro JM
Exp Dermatol; 2019 Jul; 28(7):822-828. PubMed ID: 31021014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
